Shares of Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $66.78, but opened at $65.25. Korro Bio shares last traded at $67.00, with a volume of 4,958 shares.
Wall Street Analyst Weigh In
A number of brokerages have commented on KRRO. HC Wainwright increased their target price on Korro Bio from $100.00 to $115.00 and gave the company a “buy” rating in a report on Thursday, March 28th. BMO Capital Markets reaffirmed an “outperform” rating and set a $120.00 target price on shares of Korro Bio in a report on Tuesday, March 26th. Piper Sandler reiterated an “overweight” rating and issued a $180.00 target price on shares of Korro Bio in a research report on Wednesday, March 27th. Finally, Royal Bank of Canada boosted their price target on shares of Korro Bio from $70.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 27th.
Read Our Latest Analysis on Korro Bio
Korro Bio Price Performance
Hedge Funds Weigh In On Korro Bio
A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. purchased a new stake in shares of Korro Bio in the 4th quarter valued at approximately $12,988,000. Eventide Asset Management LLC acquired a new position in Korro Bio in the fourth quarter valued at approximately $26,185,000. 72 Investment Holdings LLC purchased a new position in Korro Bio in the fourth quarter worth approximately $13,269,000. Point72 Asset Management L.P. purchased a new position in Korro Bio in the fourth quarter worth approximately $12,741,000. Finally, Verition Fund Management LLC acquired a new stake in Korro Bio during the fourth quarter worth $2,784,000. 13.18% of the stock is owned by hedge funds and other institutional investors.
About Korro Bio
Korro Bio, Inc, a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc is based in Cambridge, Massachusetts.
Featured Stories
- Five stocks we like better than Korro Bio
- Options Trading – Understanding Strike Price
- Comprehensive Analysis of PayPal Stock
- The 3 Best Retail Stocks to Shop for in August
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Korro Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Korro Bio and related companies with MarketBeat.com's FREE daily email newsletter.